Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Sanofi – Regeneron Tout Additional Positive Data From Flagship Dupixent Product

By Vandana Singh
October 11, 7:43 AM
Sanofi SA (NASDAQ:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) presented more positive data for their Dupixent product. The companies said new Dupixent data showed…

REGN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Top Stories

Despite Advancement, Benefits From Alzheimer’s Drugs May Be Limited, Say Researchers

By Vandana Singh
October 10, 3:14 PM
Recently, Biogen Inc (NASDAQ:BIIB) and Eisai Co (OTC: ESALY) announced encouraging data from the most-watched Alzheimer’s therapies in the clinic. Lecanemab cleared accumulations…

BIIB

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Janssen Touts Encouraging Data From Two Ulcerative Colitis Treatments

By Vandana Singh
October 10, 11:52 AM
Janssen Pharmaceutical, a unit of Johnson & Johnson (NYSE:JNJ), announced data from an ongoing analysis of a Phase 2a trial of guselkumab…

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Centre Piece Of Merck’s $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular Trial

By Vandana Singh
October 10, 11:27 AM
Merck & Co Inc (NYSE:MRK) announced topline results from the pivotal Phase 3 STELLAR trial evaluating the safety and…

MRK

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • News
  • Small Cap

Iradimed Withdraws FDA Application For Updated MR IV Pump System

By Vandana Singh
October 10, 11:24 AM
Iradimed Corporation (NASDAQ:IRMD) voluntarily withdrew its 510(K) application for its next-generation MRidium 3870 Infusion Pump System. Roger Susi, President and Chief…

IRMD

Read More
1 minute read
  • Contracts
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Applied DNA Sciences Stock Surges On largest LinearDNA Contract

By Vandana Singh
October 10, 11:19 AM
Applied DNA Sciences Inc (NASDAQ:APDN) received its largest single purchase order for LinearDNA valued above the mid-six figures.  The order was…

APDN

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

FDA Rejects Supernus Pharma’s Minimally Invasive Parkinson’s Therapy

By Vandana Singh
October 10, 9:27 AM
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) received FDA’s complete response letter (CRL) for the SPN-830 marketing application. SPN-830 is an investigational apomorphine infusion…

SUPN

Read More
1 minute read
  • Biotech
  • FDA
  • Financing
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

FDA Approves scPharmaceuticals’ Self-Administered Med For Congestion in Chronic Heart Failure

By Vandana Singh
October 10, 9:24 AM
The FDA has approved scPharmaceuticals Inc’s (NASDAQ:SCPH) Furoscix (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for…

SCPH

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

FDA Approves GSK’s Whooping Cough Vaccine During Pregnancy For Prevention In Infants

By Vandana Singh
October 10, 6:01 AM
The FDA has approved GSK Plc’s (NYSE:GSK) Boostrix vaccine during the third trimester of pregnancy to prevent whooping cough in infants…

GSK

Read More
2 minute read
  • General
  • Health Care
  • Media
  • News
  • Startups
  • Top Stories
  • Topics

Mark Cuban Says Americans Shouldn’t Have To Pick Between Rent, Food Or Medicine

By AJ Fabino
October 9, 3:30 PM
This article was originally published on July 29, 2022. Famed billionaire, entrepreneur and Dallas Maverick’s owner Mark Cuban thinks Americans shouldn’t have to pick between necessities such as food, medicine or rent. And he’s provided a solution for at least one of those essentials.

NVS

Posts pagination

Previous 1 … 392 393 394 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service